Skip to content

Optimizing the Efficiency and Implementation of Cash Transfers to Improve Adherence to Antiretroviral Therapy

Optimizing the Efficiency and Implementation of Cash Transfers to Improve Adherence to Antiretroviral Therapy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03351556
Enrollment
530
Registered
2017-11-24
Start date
2018-04-24
Completion date
2019-06-30
Last updated
2022-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adherence, Medication, Adherence, Patient, HIV/AIDS

Brief summary

1. Determine the dose-response relationship between a cash transfer amount and HIV viral suppression at 6 months 2. Identify the most effective cash transfer size to increase the proportion of people living with HIV infection (PLHIV) retained in care and with suppressed viral load (\<1000 copies/ml) after 6 months. (This amount will be further evaluated in a cluster randomized trial in Phase 2).

Detailed description

Participants in the control group will receive the standard HIV primary care services according to Tanzania's National Guidelines for the Management of HIV and AIDS. The study has two active intervention arms: 1. The opportunity to earn 10,000 TZS/month (\ $4.50) for up to 6 months conditional on visit attendance, and 2. The opportunity to earn 22,500 TZS/month (\ $10.00) for up to 6 months conditional on visit attendance In both intervention arms, cash transfers will be delivered a maximum of once monthly, spaced ≥28 days apart, for up to six months and delivered via an automatic mobile money system linked to a biometric identification system.

Interventions

BEHAVIORALActive Arm 1

Participants in this arm will receive the standard HIV primary care services according to Tanzania's National Guidelines for the Management of HIV and AIDS plus the opportunity to earn 10,000 TZS/month conditional on visit attendance.

BEHAVIORALActive Arm 2

Participants in this arm will receive the standard HIV primary care services according to Tanzania's National Guidelines for the Management of HIV and AIDS plus the opportunity to earn 22,500 TZS/month conditional on visit attendance.

Sponsors

National Institute of Mental Health (NIMH)
CollaboratorNIH
Rasello
CollaboratorINDUSTRY
Health for a Prosperous Nation
CollaboratorOTHER
Management and Development for Health in Tanzania
CollaboratorUNKNOWN
University of California, Berkeley
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Subject)

Masking description

Participants in the cash transfer arms will be masked to the knowledge that there are two cash value arms.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ≥18 years * Living with HIV infection * Initiated antiretroviral therapy ≤1 month prior to enrollment in the study

Exclusion criteria

\- Participants who do no provide informed consent

Design outcomes

Primary

MeasureTime frameDescription
HIV viral suppression at 6 months6 months\<1000 copies/ml

Countries

Tanzania

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 26, 2026